Ron Bentsur

Director & Chairman & CEO

Director & Chairman & CEO at Nuvectis Pharma, Inc., filing insider transactions on 2026-06-30.

Total Purchases

$250K

1 transaction

Total Sales

—

0 transactions

Companies Traded

1

1 total filings

Active Since

2026-06-30

Last: 2026-06-30

Companies

Nuvectis Pharma, Inc.

Other Reporting Insiders at Nuvectis Pharma, Inc.

Mosseri Marlio Charles
10% Owner
Last filing 2026-06-30

Transaction History

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-06-30	NVCT	Purchase	12.5K	$20.00	$250K	3.69M	SEC ↗

Ron Bentsur (Nuvectis Pharma, Inc.) Insider Trades | Tormere